RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Bowling Green, KY · Louisville, KY · Owensboro, KY · +119 more sites
3 recruiting psoriasis studies with a site in Louisville, KY.
Sponsor: Bristol-Myers Squibb
Bowling Green, KY · Louisville, KY · Owensboro, KY · +119 more sites
Sponsor: Duke University
Louisville, KY · +74 more sites
Sponsor: InventisBio Co., Ltd
Louisville, KY · +19 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.